But is it effective for weight loss
Wegovy is a GLP-1 receptor agonist licensed for chronic weight management in adults with obesity or overweight with comorbidities, whilst lisdexamfetamine is a central nervous system stimulant indicated for attention deficit hyperactivity disorder (ADHD)
Follow dosage instructions
Additional insights include vitamin utilisation, insulin sensitivity, bone strength, salt sensitivity, iron balance, oxidative stress response, and metabolism of lactose, caffeine, and alcoholfactors that directly impact resilience and long-term health
In more rare yet severe cases, you may experience irregular heartbeat or trouble breathing
Wegovy is FDA-approved for weight loss